This invention is a comprehensive questionnaire designed to assess cardiovascular health risk.

This tool leverages longitudinal data from the Study of Women’s Health Across the Nation (SWAN) to deliver personalized 10-year cardiovascular risk estimates for midlife women.

University of Pittsburgh researchers have developed a novel therapy for chondrocyte aging and, ultimately, osteoarthritis (OA).

This technology utilizes three-dimensional spheroid culture techniques to transform human pericytes isolated from the aortic adventitia into pluripotent cells.

University of Pittsburgh researchers have developed a novel approach to continuously monitor blood pressure (BP).

University of Pittsburgh and Carnegie Mellon University researchers have developed a novel molecule, CPM3-gPNA, designed to treat mitochondrial DNA (mtDNA) heteroplasmy.

Researchers at the University of Pittsburgh and the University of Pennsylvania have identified Profilin1 (Pfn1) as a novel therapeutic target for atherosclerosis.

The University of Pittsburgh has developed a technology that enhances in vivo vasculogenic reprogramming using Tissue Nanotransfection (TNT) to deliver specific transcription factors.

University of Pittsburgh researchers have developed a novel mixed reality (MR) system to improve efficiency and focus during split-attention information-mediated tasks.

University of Pittsburgh researchers have developed a novel laser surface texturing technology that fabricates defined micro grid patterns on endovascular metallic materials, such as Cobalt-Chromium (CoCr).

University of Pittsburgh researchers have developed the Easy Anastomotic System Instrument (EASI), a precision microsurgical device designed to facilitate the anastomosis of small tubular structures, such as blood vessels, without the need for expensive microscopes or specialized expertise.

University of Pittsburgh researchers have developed an innovative additive and subtractive laser-assisted rolling fabrication technique to create mesoporous, compliance-matched, and drug-eluting vascular grafts.

University of Pittsburgh researchers have developed a novel in vitro model of metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with genetic mutations (TM6SF2-167K).

A pioneering approach harnesses human-induced pluripotent stem cells (hiPSCs) to create functional, three-dimensional heart valves grown on heart organoids entirely in vitro.

University of Pittsburgh researchers have developed a viral vector that allows for the overexpression of Cdkn1a cDNA selectively in cardiomyocytes.